Prevent Cancer Foundation
The Prevent Cancer Foundation is a United States nonprofit focused on cancer prevention, early detection, research, public education, and advocacy.
Last updated August 26, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
The Prevent Cancer Foundation (PCF) is a United States-based nonprofit organization devoted to reducing the burden of cancer through prevention and early detection. Formerly known as the Cancer Research Foundation of America and later the Cancer Research and Prevention Foundation, it presents cancer prevention as a combination of scientific research, accessible screening, vaccination, public education, community outreach, and public-policy advocacy. Rather than operating as a hospital, pharmaceutical company, or disease-treatment provider, the Foundation works across the cancer-prevention ecosystem. Its activities include supporting researchers, convening professional conferences, distributing educational information, cooperating with media organizations, supporting screening and vaccination awareness, and advocating for policies intended to improve prevention and early diagnosis. Its public-facing work emphasizes practical risk reduction and the importance of identifying cancer at an earlier stage, when treatment is more likely to be effective. PCF has reported funding more than 300 scientists and more than 430 peer-reviewed research projects at leading institutions in the United States and internationally. Its work has covered broad cancer-prevention questions as well as specific areas such as colorectal cancer. The Foundation's colorectal cancer initiatives helped establish a collaborative framework for healthcare professionals working on screening and prevention, an area in which coordination had previously been limited. The organization also engages with policymakers, including through its Congressional Families Cancer Prevention Program, and seeks to translate scientific findings into public-health action. Its outreach has included exhibits, educational materials, media engagement, and programs intended to help people understand screening options, vaccination, warning signs, and ways to lower their individual cancer risk. PCF has stated an ambition to help reduce cancer deaths by 40 percent by 2035. Its described investment priorities include funding technology for early detection and multi-cancer screening, expanding screening and vaccination access in medically underserved communities, and educating the public about available prevention and detection options. The Foundation reports meeting the Better Business Bureau's 20 Standards for Charity Accountability, receiving a four-star, 100/100 Charity Navigator rating, and holding a 2022 Platinum Transparency status from GuideStar. These ratings and recognitions concern nonprofit accountability and transparency rather than commercial performance. The Foundation's positioning is therefore that of a prevention-oriented health charity connecting biomedical research, professional collaboration, community access, public communication, and legislative advocacy. Its principal beneficiaries are the public, people at elevated risk of cancer, medically underserved communities, cancer researchers, healthcare professionals, and policymakers.
History
The Prevent Cancer Foundation developed from an organization formerly known as the Cancer Research Foundation of America and subsequently as the Cancer Research and Prevention Foundation. Its institutional identity has consistently centered on preventing cancer before it develops or detecting it early enough to improve treatment prospects. The later adoption of the Prevent Cancer Foundation name made that preventive mission more explicit and easier to communicate to the general public. The Foundation's work has combined grantmaking with public-health communication. It has supported more than 300 scientists and more than 430 peer-reviewed research projects at leading research institutions in the United States and elsewhere. This research orientation has been paired with efforts to move knowledge beyond laboratories: PCF has used educational exhibits, printed and digital materials, media relationships, and public programs to explain risk reduction, cancer warning signs, screening, and vaccination. A significant part of the organization's development has involved building connections among researchers, clinicians, advocates, and policymakers. PCF has held professional conferences around the United States for people working in cancer-related fields. It has also developed advocacy activity on Capitol Hill, including the Congressional Families Cancer Prevention Program, which engages congressional families in cancer-prevention education and awareness. The Foundation's colorectal cancer work is described as particularly influential in establishing a cooperative framework for healthcare professionals involved in colorectal screening and prevention. This reflects its broader operating model: instead of concentrating exclusively on one disease, PCF supports collaboration and public action across multiple prevention and early-detection priorities. In its current strategic direction, the Foundation has articulated a goal of helping reduce cancer deaths by 40 percent by 2035. The associated priorities described by the organization include investment in technology for early cancer detection and multi-cancer screening, increased access to screening and vaccination in medically underserved communities, and expanded public education about prevention and early-detection choices. These priorities extend the Foundation's historical role from research support and awareness-building toward implementation, access, and health-equity work. PCF also emphasizes nonprofit accountability. It reports compliance with the Better Business Bureau's 20 Standards for Charity Accountability, a four-star and 100/100 rating from Charity Navigator, and 2022 Platinum Transparency participation through GuideStar. These external evaluations support its presentation as a transparent charitable organization, although they do not constitute evidence of commercial financial performance. Overall, the Foundation's history is defined by a shift from a research-centered cancer charity identity toward a broader prevention platform. Its activities now span scientific funding, professional education, community outreach, screening and vaccination access, early-detection technology, and advocacy intended to influence both individual behavior and public policy.
- 2022
GuideStar Platinum Transparency participation
[1]The Foundation was identified as a 2022 Platinum Transparency participant in GuideStar materials.
Organization established under an earlier name
[1]The organization operated originally as the Cancer Research Foundation of America before later using the Cancer Research and Prevention Foundation name.
Adoption of the Prevent Cancer Foundation identity
[1]The organization adopted its current name to foreground its mission of preventing cancer and promoting early detection.
Expansion of research support
[1]The Foundation reported supporting more than 300 scientists and more than 430 peer-reviewed research projects at leading institutions.
Development of colorectal cancer prevention collaboration
[1]Its colorectal cancer work helped create a collaborative framework for healthcare professionals involved in screening and prevention.
2035 cancer-mortality reduction ambition announced
[1]PCF stated an ambition to help reduce cancer deaths by 40 percent by 2035, supported by priorities in early detection, screening and vaccination access, and public education.
Products and positioning
A prevention-first nonprofit that links cancer research, early detection, screening and vaccination access, public education, professional collaboration, and public-policy advocacy.
Research funding
Cancer-prevention research support
PCF funds scientists and peer-reviewed projects addressing cancer prevention and early detection. Its reported portfolio spans more than 300 scientists and more than 430 projects at leading research institutions. This is philanthropic research support rather than a commercial product line, intended to advance evidence that can eventually inform screening, prevention practice, and public policy.
Public health education
Cancer-prevention education
The Foundation produces and distributes educational information through outreach, exhibits, media engagement, and other public-facing channels. The content is intended to help people understand cancer risk reduction, screening choices, vaccination, and possible warning signs, with an emphasis on practical steps that may prevent cancer or identify it earlier.
Community health access
Screening and vaccination access initiatives
PCF's strategic priorities include expanding cancer-screening and vaccination access for medically underserved communities. These initiatives address barriers to prevention and early detection by combining education, outreach, and support for broader access to established public-health interventions.
Professional education
Professional cancer-prevention conferences
The Foundation holds professional conferences for people working in cancer-related fields. These forums support exchange among researchers, clinicians, advocates, and other professionals and reinforce PCF's role as a convening organization within prevention and early-detection work.
Marketing campaigns
- Congressional Families Cancer Prevention Program
United States
A public-policy and awareness program connected with the Foundation's work on Capitol Hill. It uses congressional-family networks to promote cancer-prevention knowledge and awareness.
Outcome. The program is cited as part of PCF's broader influence on national cancer-prevention advocacy.
- Colorectal Cancer Prevention and Screening Outreach
United States
A body of Foundation activity focused on improving colorectal cancer prevention and screening collaboration among healthcare professionals and the public.
Outcome. The work helped establish a collaborative framework for professionals involved in colorectal cancer screening and prevention.
Brand decisions
- Set a 2035 cancer-death reduction ambitionStrategy
Background
The Foundation framed its long-term work around contributing to a 40 percent reduction in cancer deaths by 2035.
Action taken
It identified three investment priorities: early-detection and multi-cancer-screening technology, screening and vaccination access for medically underserved communities, and public education.
Aftermath
The ambition provides a strategic framework for combining research, access, education, and advocacy rather than treating them as separate activities.
Planned investment allocation. $20 million for early-detection technology; $10 million for screening and vaccination access; $10 million for public education (Strategic plan associated with the 2035 goal; exact timing not specified)
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/prevent-cancer-foundation · Editorial policy · How profiles are compiled